Sunflower Pharmaceutical Group Co.,Ltd
SZSE:002737.SZ
24 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 2,287.009 | 2,398.721 | 1,320.13 | 1,647.907 | 1,465.868 | 1,228.913 | 932.094 | 905.579 | 969.37 | 1,798.991 | 438.723 | 492.079 | 339.519 |
| Short Term Investments
| 1,315.105 | 1,448.671 | 668.688 | 150.49 | 205 | -4.543 | -4.381 | -5.054 | 0 | 0 | 1.75 | -3.777 | 0 |
| Cash and Short Term Investments
| 3,602.114 | 3,847.391 | 1,988.818 | 1,798.396 | 1,670.868 | 1,228.913 | 932.094 | 905.579 | 969.37 | 1,798.991 | 438.723 | 492.079 | 339.519 |
| Net Receivables
| 172.161 | 370.562 | 376.218 | 409.124 | 740.691 | 748.393 | 622.3 | 672.174 | 549.865 | 404.968 | 290.188 | 207.518 | 224.575 |
| Inventory
| 873.19 | 632.08 | 709.639 | 562.168 | 664.545 | 814.146 | 797.055 | 648.481 | 536.571 | 350.872 | 346.817 | 330.239 | 280.984 |
| Other Current Assets
| 140.499 | 11.027 | 318.254 | 167.579 | 16.808 | 260.211 | 273.153 | 276.254 | 7.818 | 1.058 | 9.868 | 5.364 | -43.323 |
| Total Current Assets
| 4,787.964 | 4,861.06 | 3,392.928 | 2,937.267 | 3,092.913 | 3,051.664 | 2,624.602 | 2,502.487 | 2,063.624 | 2,555.888 | 1,085.596 | 1,035.201 | 801.755 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 1,435.19 | 1,496.836 | 1,577.152 | 1,608.8 | 1,520.149 | 1,328.364 | 1,256.464 | 1,220.104 | 1,226.292 | 918.533 | 759.024 | 605.124 | 520.622 |
| Goodwill
| 91.774 | 91.774 | 107.603 | 134.819 | 171.547 | 171.547 | 171.547 | 150.921 | 150.921 | 37.907 | 37.907 | 37.907 | 37.907 |
| Intangible Assets
| 345.369 | 366.518 | 337.772 | 350.798 | 384.542 | 395.084 | 329.597 | 283.258 | 280.714 | 185.357 | 189.821 | 188.464 | 171.095 |
| Goodwill and Intangible Assets
| 437.143 | 458.292 | 445.375 | 485.617 | 556.089 | 566.631 | 501.144 | 434.178 | 431.635 | 223.264 | 227.727 | 226.371 | 209.002 |
| Long Term Investments
| 122.442 | -1,307.289 | -537.364 | -147.402 | -201.798 | 7.4 | 7.401 | 6.804 | 1.75 | 1.75 | -0 | 5.527 | 0 |
| Tax Assets
| 58.923 | 56.533 | 55.78 | 59.496 | 76.681 | 76.985 | 74.952 | 55.371 | 37.511 | 29.493 | 20.203 | 22.366 | 20.21 |
| Other Non-Current Assets
| 40.251 | 1,466.334 | 701.333 | 169.564 | 265.257 | 28.088 | 5.605 | 4.692 | 3.815 | 4.087 | 6.044 | -0.125 | 5.508 |
| Total Non-Current Assets
| 2,093.948 | 2,170.706 | 2,242.275 | 2,176.076 | 2,216.378 | 2,007.468 | 1,845.566 | 1,721.149 | 1,701.003 | 1,177.127 | 1,012.998 | 859.262 | 755.343 |
| Total Assets
| 6,881.913 | 7,031.766 | 5,635.204 | 5,113.343 | 5,309.29 | 5,059.132 | 4,470.168 | 4,223.636 | 3,764.627 | 3,733.015 | 2,098.593 | 1,894.463 | 1,557.098 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 734.596 | 714.482 | 547.179 | 447.879 | 528.973 | 442.804 | 397.819 | 351.435 | 327.569 | 235.965 | 220.652 | 205.693 | 146.702 |
| Short Term Debt
| 22.442 | 425.586 | 203.499 | 240.52 | 300 | 150 | 100 | 330 | 203 | 587.4 | 585.097 | 617 | 549.682 |
| Tax Payables
| 87.533 | 172.432 | 85.023 | 108.842 | 126.355 | 105.906 | 106.013 | 110.011 | 89.184 | 77.375 | 58.776 | 53.714 | 46.06 |
| Deferred Revenue
| 297.325 | 551.542 | 482.919 | 454.464 | 385.473 | 105.906 | 333.078 | 318.753 | 252.801 | 221.04 | 163.649 | 147.834 | 132.923 |
| Other Current Liabilities
| 465.551 | 483.759 | 19.009 | 15.176 | 102.424 | 515.398 | 120.637 | 70.534 | 66.126 | 10 | 2.67 | 0.937 | 0.076 |
| Total Current Liabilities
| 1,519.915 | 2,175.369 | 1,252.606 | 1,158.039 | 1,316.87 | 1,214.107 | 951.533 | 1,070.722 | 849.496 | 1,054.405 | 972.068 | 971.464 | 829.384 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 7.624 | 10.497 | 40.578 | 69.959 | 126.339 | 46.339 | 0.634 | 0.898 | 1.163 | 156.527 | 97.327 | 98.063 | 163.063 |
| Deferred Revenue Non-Current
| 342.079 | 397.262 | 389.076 | 380.367 | 414.487 | 336.631 | 325.566 | 324.957 | 276.635 | 236.803 | 1.69 | 1.953 | 2.217 |
| Deferred Tax Liabilities Non-Current
| 7.609 | 9.89 | 17.82 | 20.234 | 21.838 | 24.79 | 30.847 | 22.634 | 26.862 | 4.171 | 4.329 | 4.921 | 4.658 |
| Other Non-Current Liabilities
| -342.079 | 0 | 0 | 93.983 | 0.108 | 0.371 | 0 | 0 | 0 | 1.426 | 154.155 | 59.675 | 14.306 |
| Total Non-Current Liabilities
| 15.233 | 417.65 | 447.474 | 564.544 | 562.772 | 408.131 | 357.047 | 348.488 | 304.659 | 398.927 | 257.501 | 164.612 | 184.244 |
| Total Liabilities
| 1,535.147 | 2,593.019 | 1,700.08 | 1,722.583 | 1,879.642 | 1,622.239 | 1,308.581 | 1,419.211 | 1,154.155 | 1,453.333 | 1,229.569 | 1,136.077 | 1,013.628 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 584 | 584 | 584 | 584 | 584 | 584 | 292 | 292 | 292 | 146 | 109.5 | 109.5 | 109.5 |
| Retained Earnings
| 2,951.634 | 2,416.511 | 1,956.059 | 1,453.226 | 1,485.566 | 1,545.846 | 1,311.266 | 1,017.742 | 831.539 | 607.521 | 470.643 | 400.074 | 222.754 |
| Accumulated Other Comprehensive Income/Loss
| 567.569 | 559.23 | 554.633 | 546.64 | 474.616 | 289.082 | 250.809 | 201.34 | 166.843 | 11.504 | 9.169 | 0 | 0 |
| Other Total Stockholders Equity
| 660.237 | 645.011 | 614.715 | 596.366 | 679.937 | 853.922 | 1,138.776 | 1,126.298 | 1,158.704 | 1,451.208 | 239.017 | 223.444 | 196.95 |
| Total Shareholders Equity
| 4,763.44 | 4,204.751 | 3,709.407 | 3,180.232 | 3,224.119 | 3,272.85 | 2,992.851 | 2,637.38 | 2,449.086 | 2,216.234 | 828.329 | 733.018 | 529.204 |
| Total Equity
| 5,004.686 | 4,438.747 | 3,935.124 | 3,390.76 | 3,429.648 | 3,436.893 | 3,161.587 | 2,804.426 | 2,610.472 | 2,279.683 | 869.025 | 758.386 | 543.47 |
| Total Liabilities & Shareholders Equity
| 6,881.913 | 7,031.766 | 5,635.204 | 5,113.343 | 5,309.29 | 5,059.132 | 4,470.168 | 4,223.636 | 3,764.627 | 3,733.015 | 2,098.593 | 1,894.463 | 1,557.098 |